ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 117 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $86,837 | +55564.7% | 53,936 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $156 | -11.4% | 53,936 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $176 | -99.9% | 53,936 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $203,000 | -39.9% | 53,936 | +24.2% | 0.00% | -50.0% |
| Q2 2022 | $338,000 | -5.1% | 43,416 | +13.0% | 0.00% | 0.0% |
| Q1 2022 | $356,000 | -41.9% | 38,416 | -1.3% | 0.00% | -33.3% |
| Q4 2021 | $613,000 | -9.9% | 38,916 | +2.4% | 0.00% | -25.0% |
| Q3 2021 | $680,000 | +88.4% | 38,000 | +63.4% | 0.00% | +100.0% |
| Q2 2021 | $361,000 | -18.1% | 23,250 | -24.4% | 0.00% | -33.3% |
| Q1 2021 | $441,000 | 0.0% | 30,750 | +36.7% | 0.00% | 0.0% |
| Q4 2020 | $441,000 | +51.5% | 22,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $291,000 | – | 22,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |